
|Videos|April 8, 2022
Novel stone treatment gets first trial in human subjects
Author(s)Urology Times staff
“We saw that this appears to be a safe treatment with very little bleeding,” says Jonathan D. Harper, MD.
Advertisement
In this video, Jonathan D. Harper, MD, discusses the background and key findings of the Journal of Urology study, “Fragmentation of Stones by Burst Wave Lithotripsy in the First 19 Humans,” for which he served as a study author. Harper is an associate professor of urology and adjunct associate professor of surgery at the University of Washington School of Medicine in Seattle.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves sildenafil oral film for men with erectile dysfunction
2
The UroOnc Minute: Adjuvant Therapy in Renal Cell Carcinoma, with Brian Shuch, MD
3
Head-to-head analysis shows OS benefit with apalutamide vs darolutamide in mCSPC
4
Phase 1/2 trial launches of molecular glue degrader for ccRCC
5






